{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:32:31Z","timestamp":1773696751520,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commission of Pakistan","doi-asserted-by":"publisher","award":["20-3733\/NRPU\/R&D\/14\/520"],"award-info":[{"award-number":["20-3733\/NRPU\/R&D\/14\/520"]}],"id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"DAAD","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bioorg.2019.03.067","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T15:19:42Z","timestamp":1554218382000},"page":"102893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Probing the high potency of pyrazolyl pyrimidinetriones and thioxopyrimidinediones as selective and efficient non-nucleotide inhibitors of recombinant human ectonucleotidases"],"prefix":"10.1016","volume":"88","author":[{"given":"Hina","family":"Andleeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2922-1600","authenticated-orcid":false,"given":"Shahid","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda Abida","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imtiaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumera","family":"Zaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Lecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"S\u00e9vigny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamshed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.03.067_h0005","article-title":"Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase\/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors","volume":"703\u201343","author":"Al-Rashida","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2019.03.067_h0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11302-005-5303-4","article-title":"Modulation of purinergic signaling by NPP-type ectophosphodiesterases","volume":"2","author":"Stefan","year":"2006","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bioorg.2019.03.067_b0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10409230091169249","article-title":"Nucleotide pyrophosphatases\/phosphodiesterases on the move","volume":"35","author":"Bollen","year":"2000","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2019.03.067_b0015","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.bmc.2016.05.046","article-title":"Thiazolo[3,2-a]benzimidazol-3(2H)-one derivatives: structure-activity relationships of selective nucleotide pyrophosphatase\/phosphodiesterase1 (NPP1) inhibitors","volume":"24","author":"Lee","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bioorg.2019.03.067_b0025","doi-asserted-by":"crossref","first-page":"10080","DOI":"10.1021\/jm501434y","article-title":"Imidazopyridine-and purine-thioacetamide derivatives: potent inhibitors of nucleotide pyrophosphatase\/phosphodiesterase 1 (NPP1)","volume":"57","author":"Chang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0030","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1016\/j.bmc.2006.07.037","article-title":"New biscoumarin derivatives-cytotoxicity and enzyme inhibitory activities","volume":"14","author":"Choudhary","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0035","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1039\/C7MD00015D","article-title":"Nucleotide pyrophosphatase\/phosphodiesterase 1 (NPP1) and its inhibitors","volume":"8","author":"Lee","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.bioorg.2019.03.067_b0040","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/np300026p","article-title":"Isolation and characterization of \u03b1, \u03b2-unsaturated \u03b3-lactono-hydrazides from Streptomyces sp","volume":"75","author":"Le Goff","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2019.03.067_h0050","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1073\/pnas.85.9.3024","article-title":"Seminoma-derived Nagao isozyme is encoded by a germ-cell alkaline phosphatase gene","volume":"85","author":"Millan","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2019.03.067_h0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11302-005-5435-6","article-title":"Alkaline phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes","volume":"2","author":"Mill\u00e1n","year":"2006","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bioorg.2019.03.067_h0060","first-page":"286","article-title":"Infantile hypophosphatasia: localization within chromosome region 1p36.1-34 and prenatal diagnosis using linked DNA markers","volume":"46","author":"Greenberg","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bioorg.2019.03.067_h0065","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1128\/AEM.62.10.3732-3738.1996","article-title":"Production of two extracellular alkaline phosphatases by a psychrophilic arthrobacter strain","volume":"62","author":"De Prada","year":"1996","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bioorg.2019.03.067_h0070","first-page":"1039","article-title":"Anti-oxidative effect of a protein from Cajanus indicus L against acetaminophen-induced hepato-nephro toxicity","volume":"40","author":"Ghosh","year":"2007","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2019.03.067_h0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0022-2836(91)90724-K","article-title":"Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis","volume":"218","author":"Kim","year":"1991","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2019.03.067_b0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1389557515666150219113205","article-title":"Inhibition of alkaline phosphatase: an emerging new drug target","volume":"15","author":"Al-Rashida","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jbmr.195","article-title":"Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification","volume":"26","author":"Yadav","year":"2011","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.bioorg.2019.03.067_b0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jss.2010.04.048","article-title":"The protective role of intestinal alkaline phosphatase in necrotizing enterocolitis","volume":"163","author":"Whitehouse","year":"2010","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bioorg.2019.03.067_b0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1753-4887.2010.00292.x","article-title":"Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet","volume":"68","author":"Lall\u00e8s","year":"2010","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.bioorg.2019.03.067_b0075","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1359\/jbmr.2003.18.6.994","article-title":"Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression","volume":"18","author":"Johnson","year":"2003","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bioorg.2019.03.067_b0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0968-0004(92)90246-6","article-title":"Hydrolysis of phosphate monoesters: a biological problem with multiple chemical solutions","volume":"17","author":"Vincent","year":"1992","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bioorg.2019.03.067_b0085","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.ATV.0000158943.79580.9d","article-title":"Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype","volume":"25","author":"Towler","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bioorg.2019.03.067_b0090","article-title":"Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD","volume":"429\u2013442","author":"Haarhaus","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bioorg.2019.03.067_b0095","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0530278100","article-title":"Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum","volume":"100","author":"Welsh","year":"2003","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.bioorg.2019.03.067_b0100","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1021\/jm900383s","article-title":"Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP)","volume":"52","author":"Dahl","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0105","first-page":"1","volume":"vol. 3","year":"1996","journal-title":"Comprehensive Heterocyclic Chemistry II"},{"key":"10.1016\/j.bioorg.2019.03.067_b0110","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejmech.2013.08.053","article-title":"Pyrazole containing natural products: synthetic preview and biological significance","volume":"69","author":"Kumar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0115","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1021\/jm960444z","article-title":"New potent antihyperglycemic agents in db\/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl)(trifluoromethyl)pyrazoles and -pyrazolones","volume":"39","author":"Kees","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0223-5234(98)80002-0","article-title":"Nonsteroidal antiinflammatory agents \u2013 Part 1: Antiinflammatory, analgesic and antipyretic activity of some new 1-(pyrimidin-2-yl)-3-pyrazolin-5-ones and 2-(pyrimidin-2-yl)-1,2,4,5,6,7-hexahydro-3H-indazol-3-ones","volume":"33","author":"Badawey","year":"1998","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_h0150","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/ijms17091499","article-title":"Synthesis and characterization of some new bis-pyrazolyl-thiazoles incorporating the thiophene moiety as potent anti-tumor agents","volume":"17","author":"Gomha","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2019.03.067_h0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00706-014-1303-9","article-title":"Synthesis, characterization, and pharmacological evaluation of some novel thiadiazoles and thiazoles incorporating pyrazole moiety as anticancer agents","volume":"146","author":"Gomha","year":"2015","journal-title":"Monatsh Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_h0160","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1570179412666150828195202","article-title":"Synthesis of new thiazole derivatives as antitumor agents","volume":"13","author":"Abbas","year":"2016","journal-title":"Curr. Org. Synth."},{"key":"10.1016\/j.bioorg.2019.03.067_h0165","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/jm990383f","article-title":"Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives","volume":"43","author":"Genin","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_h0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3906\/kim-1506-13","article-title":"Synthesis and evaluation of some novel thiazoles and 1,3-thiazines as potent agents against the rabies virus","volume":"40","author":"Abdalla","year":"2016","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0135","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/jhet.2790","article-title":"Synthetic utility of pyridinium bromide: synthesis and antimicrobial activity of novel 2,4,6-trisubstituted pyridines having pyrazole moiety","volume":"54","author":"Gomha","year":"2017","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0140","doi-asserted-by":"crossref","first-page":"86428","DOI":"10.1039\/C5RA17568B","article-title":"Synthesis, characterization and biological evaluation of N-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)benzamides","volume":"5","author":"Saeed","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.03.067_b0145","doi-asserted-by":"crossref","first-page":"77688","DOI":"10.1039\/C6RA14531K","article-title":"Identification of novel pyrazole\u2013rhodanine hybrid scaffolds as potent inhibitors of aldose reductase: design, synthesis, biological evaluation and molecular docking analysis","volume":"6","author":"Andleeb","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.03.067_b0150","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1039\/C6OB02236G","article-title":"New one-pot synthesis of N-fused isoquinoline derivatives by palladium-catalyzed C-H arylation: potent inhibitors of nucleotide pyrophosphatase-1 and -3","volume":"14","author":"Ausekle","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0155","doi-asserted-by":"crossref","first-page":"90806","DOI":"10.1039\/C5RA14836G","article-title":"Influence of the diversified structural variations at the imine functionality of 4-bromophenylacetic acid derived hydrazones on alkaline phosphatase inhibition: synthesis and molecular modelling studies","volume":"5","author":"Khan","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.03.067_b0160","doi-asserted-by":"crossref","first-page":"107556","DOI":"10.1039\/C6RA22750C","article-title":"Synthesis of 2-arylated thiadiazolopyrimidones by Suzuki-Miyaura cross-coupling: a new class of nucleotide pyrophosphatase (NPPs) inhibitors","volume":"6","author":"Jafari","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.03.067_b0165","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1016\/j.bmcl.2014.07.013","article-title":"Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1","volume":"24","author":"Bravo","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.03.067_b0170","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1432-1033.1994.tb20068.x","article-title":"Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities","volume":"226","author":"Belli","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0175","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/geno.1997.4949","article-title":"Molecular cloning and chromosomal localization of PD-Ibeta (PDNP3), a new member of the human phosphodiesterase I genes","volume":"45","author":"Jinhua","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.bioorg.2019.03.067_b0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11302-005-6217-x","article-title":"Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8","volume":"1","author":"Kukulski","year":"2005","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bioorg.2019.03.067_b0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2019.03.067_b0190","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/nprot.2010.86","article-title":"High-throughput screening of tissue-nonspecific alkaline phosphatase for identification of effectors with diverse modes of action","volume":"5","author":"Sergienko","year":"2010","journal-title":"Nat. Prot."},{"key":"10.1016\/j.bioorg.2019.03.067_b0195","unstructured":"MOE (Molecular Operating Environment) Version 2014.0901. Chemical Computing Group, (CCG). http:\/\/www.chemcomp.com\/MOEMolecular_Operating_ Environment.htm."},{"key":"10.1016\/j.bioorg.2019.03.067_b0200","unstructured":"Labute, P. Protonate 3D: Assignment of Macromolecular Protonation State and Geometry, Chemical Computing Group, 2007. http:\/\/www.chemcomp.com\/journal\/proton.htm."},{"key":"10.1016\/j.bioorg.2019.03.067_b0205","unstructured":"LeadIT, 2014, at http:\/\/www.biosolveit.de\/LeadIT."},{"key":"10.1016\/j.bioorg.2019.03.067_b0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10822-012-9626-2","article-title":"A consistent description of HYdrogen bond and DEhydration energies in protein-ligand complexes: methods behind the HYDE scoring function","volume":"27","author":"Schneider","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2019.03.067_b0215","series-title":"Discovery Studio Modeling Environment, Release 4.0","author":"Accelrys Software Inc.","year":"2013"},{"key":"10.1016\/j.bioorg.2019.03.067_b0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.bioorg.2019.03.067_b0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0022-1759(90)90309-J","article-title":"Towards an optimized MTT assay","volume":"130","author":"Niks","year":"1990","journal-title":"J. Immunol. Meth."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T10:11:54Z","timestamp":1607163114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818309829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":53,"alternative-id":["S0045206818309829"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.067","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing the high potency of pyrazolyl pyrimidinetriones and thioxopyrimidinediones as selective and efficient non-nucleotide inhibitors of recombinant human ectonucleotidases","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102893"}}